Nanion 运营日志


08.04.2020: Nanion Newsbites - March 2020 Recap

Nanion Newsbites: March 2020 Highlights

In the latest edition of our quarterly recap we present a cross-industry study that was performed to collect hERG data on 28 drugs with known torsadogenic risk using a standardized experimental protocol.

Acess the CiPA publication here: A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm

Additionally, we announced our next webinar: "Validation and optimization of automated patch clamp voltage-gated Ca2+ channel assays"

Date: 28. April 2020

Time: 4:00 PM CET / 10:00 AM EDT

Dr. Marc Rogers (Chief Scientific Officer at Metrion Biosciences) and Dr. András Horváth (Application Scientists at Nanion Technologies) will lead a conversation discussing voltage-gated Ca2+ channel assays and a case example of a drug discovery collaboration that spanned 8 years. 

Register for the webinar
 (Join the conversation Live or Sign up to receive an On-Demand copy)

Lastly, we caught up with Jason Villagomez (Marketing Manager) for a Q&A. Read the full Employee Interview here.

Register for our newsletter here 
(please note that you can unsubscribe or edit your email preferences at anytime)


We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.